Bicycle Therapeutics
BCYC
Bicycle Therapeutics (BCYC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $14.00 from $15.00 | Jul 30, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $12.00 from $13.00 | Apr 8, 2026 |
| Needham | Maintained | Buy | $15.00 from $24.00 | Mar 18, 2026 |
| RBC Capital | Maintained | Sector Perform | $7.00 from $11.00 | Mar 18, 2026 |
| Oppenheimer | Maintained | Outperform | $36.00 from $44.00 | Mar 18, 2026 |
| Citizens | Maintained | Market Outperform | $8.00 from $12.00 | Mar 18, 2026 |
| Truist Securities | Initiated Coverage | Hold | $10.00 | Nov 24, 2025 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $11.00 from $27.00 | Oct 31, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $13.00 from $17.00 | Aug 12, 2025 |
| JMP Securities | Maintained | Market Outperform | $10.00 from $22.00 | Aug 12, 2025 |
| Oppenheimer | Maintained | Outperform | $44.00 from $48.00 | Aug 11, 2025 |
| RBC Capital | Maintained | Outperform | $25.00 from $32.00 | Jul 17, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $17.00 from $15.00 | May 6, 2025 |
| Needham | Maintained | Buy | $29.00 | May 2, 2025 |
| B. Riley Securities | Maintained | Neutral | $14.00 from $17.00 | May 2, 2025 |
| JMP Securities | Maintained | Market Outperform | $22.00 from $26.00 | May 2, 2025 |
| RBC Capital | Maintained | Outperform | $32.00 from $35.00 | May 2, 2025 |
| Barclays | Maintained | Overweight | $15.00 from $40.00 | May 1, 2025 |
| Needham | Maintained | Buy | $30.00 | Apr 9, 2025 |
| Needham | Maintained | Buy | $30.00 | Mar 11, 2025 |
Frequently asked questions
What is the latest analyst rating on BCYC?
On Jul 30, 2026, Needham maintained Bicycle Therapeutics at Buy with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
